Data / Drug companies / Citalopram
Citalopram: 31 companies and 77 products in the FDA NDC directory
Citalopram is listed in the FDA National Drug Code Directory by 31 companies, with 77 products in commercial distribution. 65 of the products (84.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; pellet, and the newest product started marketing on June 10, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 31
- Products
- 77
- Generic (ANDA) products
- 65 (84.4%)
- Application numbers
- 10
- Routes
- Oral
- Brand names
- Celexa
- openFDA record search
- api.fda.gov
Companies that list citalopram
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hahnemann Laboratories, Inc. | 8 | pellet | Unapproved homeopathic products | June 6, 2022 |
| Remedyrepack Inc. | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | September 11, 2025 |
| Northwind Health Company, LLC | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | October 21, 2022 |
| A-S Medication Solutions | 3 | tablet | Generic drugs (ANDA) | July 22, 2016 |
| Allergan, Inc. | 3 | tablet, film coated | New drug applications (NDA) | July 17, 1998 |
| Amneal Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | April 6, 2010 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | November 10, 2017 |
| Asclemed USA Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 18, 2007 |
| Cipla USA Inc. | 3 | tablet | Generic drugs (ANDA) | July 22, 2016 |
| Coupler LLC | 3 | tablet, film coated | Generic drugs (ANDA) | June 10, 2026 |
| Epic Pharma, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 20, 2011 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | November 10, 2017 |
| Mylan Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 28, 2008 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | April 6, 2010 |
| Torrent Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | October 18, 2007 |
| Advanced Rx of Tennessee, LLC | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | November 7, 2025 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | July 28, 2008 |
| Cardinal Health 107, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | November 2, 2009 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | November 2, 2009 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, film coated | Generic drugs (ANDA) | January 23, 2014 |
| Almatica Pharma LLC | 1 | capsule | New drug applications (NDA) | January 31, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | October 1, 2012 |
| Aurobindo Pharma Limited | 1 | capsule | Generic drugs (ANDA) | March 13, 2026 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | October 18, 2007 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | June 14, 2006 |
| Chartwell RX, LLC | 1 | solution | Generic drugs (ANDA) | June 14, 2006 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 29, 2005 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution | Generic drugs (ANDA) | May 25, 2004 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 28, 2008 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 18, 2007 |
| QPharma, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 18, 2007 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 42 | 54.5% |
| Tablet | 22 | 28.6% |
| Pellet | 8 | 10.4% |
| Solution | 3 | 3.9% |
| Capsule | 2 | 2.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 65 | 84.4% |
| Unapproved homeopathic products | 8 | 10.4% |
| New drug applications (NDA) | 4 | 5.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 77 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.